MOCELLIN, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 20.016
EU - Europa 2.019
AS - Asia 1.659
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 4
OC - Oceania 4
Totale 23.719
Nazione #
US - Stati Uniti d'America 20.002
CN - Cina 836
SG - Singapore 625
IT - Italia 427
FI - Finlandia 368
DE - Germania 320
SE - Svezia 252
UA - Ucraina 215
FR - Francia 162
GB - Regno Unito 160
VN - Vietnam 111
IE - Irlanda 54
IN - India 47
NL - Olanda 33
HK - Hong Kong 14
CA - Canada 12
EU - Europa 6
IR - Iran 6
RO - Romania 5
RU - Federazione Russa 5
BR - Brasile 4
PK - Pakistan 4
PL - Polonia 3
TR - Turchia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
AU - Australia 2
CH - Svizzera 2
CL - Cile 2
CO - Colombia 2
DK - Danimarca 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
AR - Argentina 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BZ - Belize 1
CY - Cipro 1
EG - Egitto 1
ES - Italia 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
JP - Giappone 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 23.719
Città #
Fairfield 3.455
Woodbridge 2.241
Houston 1.812
Ann Arbor 1.632
Ashburn 1.463
Chandler 1.216
Seattle 1.209
Cambridge 1.156
Wilmington 1.116
Jacksonville 998
Singapore 478
Princeton 431
Boardman 413
San Diego 358
Beijing 185
Santa Clara 182
Padova 168
Helsinki 151
Medford 136
Nanjing 127
Des Moines 125
Roxbury 121
Dong Ket 111
Shenyang 56
Dublin 51
New York 48
London 46
Hebei 44
Nanchang 37
Milan 35
Redwood City 34
Jiaxing 33
Norwalk 33
Tianjin 29
Guangzhou 27
Ogden 26
Changsha 23
Detroit 17
Kilburn 17
Indiana 16
Kharkiv 16
Jinan 15
Nürnberg 15
Renton 14
Tappahannock 14
Washington 14
Hong Kong 12
Leiden 12
Cagliari 10
Los Angeles 10
Rome 10
Borås 9
Chicago 9
Vicenza 9
Buffalo 8
Chiswick 8
Falls Church 8
Frankfurt am Main 8
Haikou 8
Hefei 8
Zhengzhou 8
Dearborn 7
Orange 7
Pune 7
San Francisco 7
Shanghai 7
Verona 6
Acton 5
Agordo 5
Amsterdam 5
Dallas 5
Hangzhou 5
Hounslow 5
Lappeenranta 5
Ningbo 5
Pavia 5
Phoenix 5
Portland 5
Redmond 5
Taiyuan 5
Coral Gables 4
Munich 4
Rockville 4
Southwark 4
Taizhou 4
Wandsworth 4
Yellow Springs 4
Bolzaneto 3
Cesiomaggiore 3
Edinburgh 3
Edmonton 3
Fremont 3
Groningen 3
Harbin 3
Las Vegas 3
Mira 3
Prescot 3
Rubano 3
San Jose 3
Toronto 3
Totale 20.254
Nome #
Treatment efficacy with electrochemotherapy: A multi-institutional prospective observational study on 376 patients with superficial tumors 197
Enhanced EGFR Targeting Activity of Plasmonic Nanostructures with Engineered GE11 Peptide 178
Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. 177
Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression 173
Clinical Considerations on Sentinel Node Biopsy in Melanoma from an Italian Multicentric Study on 1,313 Patients (SOLISM-IMI) 163
Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases. 163
Can sentinel node biopsy be safely omitted in thin melanoma? Risk factor analysis of 1272 multicenter prospective cases 162
Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA- Cw*0702-associated epitope MAGE-A12 : 170-178 161
Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma 160
TNF-based isolated limb perfusion followed by consolidation biotherapy with systemic low-dose interferon alpha 2b in patients with in-transit melanoma metastases: a pilot trial. 157
E2F1 germline copy number variations and melanoma susceptibility 156
MiRNA deregulation targets specific pathways in leiomyosarcoma development: An in silico analysis 153
Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer 147
Colorectal liver metastasis:towards the integration of conventional and molecularly targeted therapeutic approaches 147
A case of "en bloc" excision of a chest wall leiomyosarcoma and closure of the defect with non-cross-linked collagen matrix (Egis®) 147
Adherence to treatment guidelines for primary sarcomas affects patient survival: a side study of the European CONnective TIssue CAncer NETwork (CONTICANET). 144
BRAF gene copy number and mutant allele frequency correlate with time to progression in metastatic melanoma patients treated with MAPK inhibitors 143
Cytokines and immune response in the tumor microenvironment 136
Unmasking cryptic epitopes after loss of immunodominant tumor antigen expression through epitope spreading 135
Bleomycin-Based Electrochemotherapy: Clinical Outcome from a Single Institution's Experience with 52 Patients. 135
The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis 134
Cancer rejection by the immune system: forcing the check-points of tumor immune escape. 133
Cytoreductive surgery alone or combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei 131
Actual false-negative rate prompts the routine use of ultrasound scan before and after sentinel node biopsy in melanoma 128
Correlation between melphalan pharmacokinetics and hepatic toxicity following hyperthermic isolated liver perfusion for unresectable metastatic disease 128
DNA array-based gene profiling in tumor immunology 127
Adjuvant immunotherapy for solid tumors: promise to clinical application 126
Gastrointestinal stromal tumors: from a surgical to a molecular approach. 126
Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade 126
Targeted therapy for colorectal cancer: mapping the way 125
Stop flow technique for loco-regional delivery of antiblastic agents: literature review and personal experience 125
Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR). 122
Support vector machine learning model for the prediction of sentinel node status in patients with cutaneous melanoma 122
Genetic susceptibility to bone and soft tissue sarcomas: A field synopsis and meta-analysis 122
New paradigm for stage III melanoma: From surgery to adjuvant treatment 122
Circadian pathway genetic variation and cancer risk: Evidence from genome-wide association studies 121
IL-10 stimulatory effects on human NK cells explored by gene profile analysis 119
Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. 117
Isolated limb perfusion for the management limb threatening soft tissue sarcomas: The role of histological type on clinical outcomes 117
First- and second-line systemic treatments for metastatic and locally advanced soft tissue sarcomas in adults 117
RNA interference: ready to silence cancer? 116
Separate cavity margins excision as a complement to conservative breast cancer surgery 116
Small datasets to develop and validate prognostic models may be a necessary evil to study rare tumours 116
Interferon Alpha Adjuvant Therapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis 115
Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study 115
Recent advances in conventional and molecular prognostic factors for gastric carcinoma 113
Circulating tumor cells in solid cancer: tumor marker of clinical relevance? 113
Molecular oncology in the post-genomic era: the challenge of proteomics 113
The Melanoma Molecular Map Project 113
Genetic variation of clock genes and cancer risk: a field synopsis and meta-analysis 113
Pelvic lymph node status prediction in melanoma patients with inguinal lymph node metastasis 113
Gold Nanoparticle Aggregates Functionalized with Cyclic RGD Peptides for Targeting and Imaging of Colorectal Cancer Cells 113
Quantitative real-time PCR: a powerful ally in cancer research. 112
Molecular markers of lymph node disease in melanoma 112
Hyperthermic isolated perfusion with low-dose tumor necrosis factor alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcomas. 112
Tumor necrosis factor (TNF) biology and cell death 112
The Effect of Lymph Node Dissection on the Survival of Patients With Operable Gastric Carcinoma 112
Differences in telomere length between sporadic and familial cutaneous melanoma 112
Validation of the new AJCC TNM staging system for gastric cancer in a large cohort of patients (n=2,155): Focus on the T category 112
Cancer vaccines: The challenge of developing an ideal tumor killing system 111
Doxorubicin activity is enhanced by hyperthermia in a model of ex vivo vascular perfusion of human colon carcinoma 111
Sentinel lymph node molecular ultrastaging in patients with melanoma: A systematic review and meta-analysis of prognosis 109
Circulating tumor cells: the 'leukemic phase' of solid cancers 109
DNA repair gene polymorphisms and risk of cutaneous melanoma: a systematic review and meta-analysis 109
Human miRNome profiling in colorectal cancer and liver metastasis development 109
Systemic treatments for metastatic cutaneous melanoma 109
The challenge of implementing high-throughput technologies in clinical trials 108
Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates 108
Genetic variation and gastric cancer risk: a field synopsis and meta-analysis. 108
Myoepithelioma of the soft tissue: A systematic review of clinical reports 108
MHC-peptide specificity and T-cell epitope mapping: where immunotherapy starts 107
Peptide-Based Anticancer Vaccines: Recent Advances and Future Perspectives 107
Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? 106
Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma 106
Short-term kinetics of tumor antigen expression in response to vaccination 105
Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: A network meta-analysis 105
Basal cell carcinoma: 10-year experience with electrochemotherapy 105
The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients 104
Maximizing the clinical usefulness of a nomogram to select patients candidate to sentinel node biopsy for cutaneous melanoma 104
RNA interference: learning gene knock-down from cell physiology 103
Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness 103
N-Ratio: a Novel Independent Prognostic Factor for Patients with Stage-III Cutaneous Melanoma. 103
Induction of endothelial nitric oxide synthase expression by melanoma sensitizes endothelial cells to tumor necrosis factor- driven cytotoxicity 103
Adult soft tissue sarcomas:Conventional therapies and molecularly targeted approaches 102
Risk-reducing medications for primary breast cancer: A network meta-analysis 102
Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: A population-based study of 8,177 cases 101
Prototyping a precision oncology 3.0 rapid learning platform 101
Understanding the good and poor cell targeting activity of gold nanostructures functionalized with molecular units for the epidermal growth factor receptor 101
Intraperitoneal chemotherapy in patients pretreated for ovarian cancer matched with patients treated with parenteral chemotherapy 100
DNA array-based gene profiling: From surgical specimen to the molecular portrait of cancer 99
Hyperthermic isolated liver perfusion for unresectable liver cancers: pilot study. 99
Cancer vaccine development: on the way to break immune tolerance to malignant cells 98
Role of resection margins in patients treated with breast conservation surgery 97
Histopathological characteristics of subsequent melanomas in patients with multiple primary melanomas. 96
Therapeutics targeting tumor immune escape: Towards the development of new generation anticancer vaccines 96
Interventions for cutaneous sarcoidosis 96
A gene expression signature associated with survival in metastatic melanoma 95
Part II: Vaccines for haematological malignant disorders 95
Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab 95
The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study. 95
Totale 12.003
Categoria #
all - tutte 84.195
article - articoli 81.306
book - libri 198
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.138
Totale 167.837


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.691 0 0 0 0 588 401 509 645 570 482 329 167
2020/20213.659 214 201 213 278 114 453 160 294 576 415 364 377
2021/20223.924 82 450 634 235 151 183 254 480 139 80 487 749
2022/20232.511 574 260 52 310 404 289 14 154 298 26 96 34
2023/20241.451 70 189 149 100 97 143 114 93 84 50 183 179
2024/20251.518 31 417 282 225 563 0 0 0 0 0 0 0
Totale 23.936